Nuwellis (NUWE) EBITDA Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,161.00 |
| Dec 31, 2025 | -11,842.00 |
| Sep 30, 2025 | 74,906.00 |
| Jun 30, 2025 | -56,960.00 |
| Mar 31, 2025 | -9,514.00 |
| Dec 31, 2024 | -16,272.00 |
| Sep 30, 2024 | 45,164.00 |
| Jun 30, 2024 | -11,853.00 |
| Mar 31, 2024 | -1,523.00 |
| Dec 31, 2023 | -7,871.00 |
| Sep 30, 2023 | 9,373.00 |
| Jun 30, 2023 | 12,176.00 |
| Mar 31, 2023 | -27,722.00 |
| Dec 31, 2022 | 10,933.00 |
| Sep 30, 2022 | 632.00 |
| Jun 30, 2022 | 3,872.00 |
| Mar 31, 2022 | 3,288.00 |
| Dec 31, 2021 | 1,929.00 |
| Sep 30, 2021 | -9,588.00 |
| Jun 30, 2021 | 8,373.00 |
| Mar 31, 2021 | -6,224.00 |
| Dec 31, 2020 | 1,398.00 |
| Sep 30, 2020 | -1,348.00 |
| Jun 30, 2020 | 6,980.00 |
| Mar 31, 2020 | 4,532.00 |
| Dec 31, 2019 | 3,431.00 |
| Sep 30, 2019 | -9,572.00 |
| Jun 30, 2019 | 12,488.00 |
| Mar 31, 2019 | -10,516.00 |
| Dec 31, 2018 | 2,717.00 |
| Sep 30, 2018 | 6,939.00 |
| Jun 30, 2018 | 3,915.00 |
| Mar 31, 2018 | 43,920.00 |
| Dec 31, 2017 | -56,137.00 |
| Sep 30, 2017 | -1,253.00 |
| Jun 30, 2017 | -18,063.00 |
| Mar 31, 2017 | 28,430.00 |
| Dec 31, 2016 | 33,373.00 |
| Mar 31, 2015 | -818,418.00 |
| Dec 31, 2014 | 659,435.00 |